BSX stock forecast
Our latest prediction for Boston Scientific Corp.'s stock price was made on the March 14, 2019 when the stock price was at 40.05$.
In the short term (2weeks), BSX's stock price should outperform the market by 0.51%. During that period the price should oscillate between -3.08% and +3.25%.
In the medium term (3months), BSX's stock price should outperform the market by 2.35%. During that period the price should oscillate between -7.33% and +10.65%.Get email alerts
Create a solid portfolio with BSX
About Boston Scientific Corp.
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
At the moment the company generates 10157M USD in revenues.
On its last earning announcement, the company reported a profit of 2.82$ per share.
The book value per share is 5.60$
Three months stock forecastMarch 14, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|